Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.

Yamagiwa, Satoshi

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C. [electronic resource] - International journal of medical sciences 2017 - 403-411 p. digital

Publication Type: Journal Article

1449-1907

10.7150/ijms.18784 doi


Adult
Aged
Aged, 80 and over
B7-H1 Antigen--blood
Carcinoma, Hepatocellular--blood
Drug Therapy, Combination
Female
Genotype
Hepatitis C, Chronic--blood
Humans
Interferon-gamma--administration & dosage
Liver Neoplasms--blood
Male
Middle Aged
Oligopeptides--administration & dosage
Ribavirin--administration & dosage
Simeprevir--administration & dosage